A study of NKR-2 in combination with chemotherapy
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2017
At a glance
- Drugs NKR 2 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SHRINK
- 20 Jul 2017 Status changed from planning to recruiting according to a Celyad media release.
- 03 Apr 2017 New trial record
- 23 Mar 2017 According to a Celyad media release, the company plans to initiate this trial in the second quarter of 2017.